| BrdU | 5-Bromo-2′-Deoxyuridine |
| CAF | Cancer-Associated Fibroblast |
| CSC | Cancer Stem Cell |
| DDS | Drug Delivery System |
| ECM | Extracellular Matrix |
| EMDR | Environment-Mediated Drug Resistance |
| EMT | Epithelial-to-Mesenchymal Transition |
| FAK | Focal Adhesion Kinase |
| FFA | Free Fatty Acid |
| FLIM | Fluorescence Lifetime Imaging Microscopy |
| FGF2 | Fibroblast Growth Factor 2 |
| H69/AR | Adriamycin-Resistant Lung Carcinoma Cells |
| HLF | Human Lung Fibroblast |
| HUVEC | Human Umbilical Vein Endothelial Cell |
| IFP | Interstitial Fluid Pressure |
| NCI | National Cancer Institute |
| NK | Natural Killer (Cell) |
| MAPK | Mitogen-activated Protein Kinase |
| O.D. | Optical Density |
| PI3K | Phosphoinositide 3-kinase |
| ROS | Reactive Oxygen Species |
| SEM | Scanning Electron Microscopy |
| SHG | Second Harmonic Generation |
| TAM | Tumor-Associated Macrophage |
| TEM | Transmission Electron Microscopy |
| TME | Tumor Microenvironment |
| T.O.F | Time-of-Flight |
| VEGF | Vascular Endothelial Growth Factor |
| YAP/TAZ | Yes-associated protein/Transcriptional coactivator with PDZ-binding motif |